NOMAD Power Solutions, Inc.(NMAD)

Biotechnology · Boca Raton, FL

$4.23+0.22 (+5.35%)

Delayed quote: Oct 6, 2026, 3:15 PM EDT

Price/OCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/OCF ratio is N/A as of 2026-10-06T19:17:48.602Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:17:48.602Z.

Quote observation: 2026-10-06T19:15:09.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 52,282,314
TTM operating cash flow · period ending 2026-06-30: -5,348,123

FMP input reference: f372f39edc86e990c580289f142e0fc1828f45467bffd466be8591b91f734aee

P/E Ratio|P/FCF Ratio|Operating Cash Flow|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

NMAD Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

NMAD Competitors' Price/OCF Ratio

NMAD

NOMAD Power Solutions, Inc.

Current

Market Cap

$52.28M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ZYBT

Zhengye Biotechnology Holding Limited

vs NMAD

Market Cap

$52.13M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs NMAD

Market Cap

$52.05M

Price/OCF Ratio

2.14

TTM Avg

2.08

3Y Avg

4.49

5Y Avg

3.97

EXOZ

eXoZymes, Inc.

vs NMAD

Market Cap

$51.51M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMA

ImageneBio Inc

vs NMAD

Market Cap

$53.24M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALDX

Aldeyra The

vs NMAD

Market Cap

$53.30M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELOX

Eloxx Pharmaceuticals, Inc.

vs NMAD

Market Cap

$51.03M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RANI

Rani Therapeutics Holdings, Inc.

vs NMAD

Market Cap

$53.63M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TENX

Tenax Therapeutics, Inc.

vs NMAD

Market Cap

$50.93M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDAI

Spectral AI, Inc.

vs NMAD

Market Cap

$53.78M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
NOMAD Power Solutions, Inc. (NMAD)	$52.28M	N/A	N/A	N/A	N/A
Zhengye Biotechnology Holding Limited (ZYBT)vs ›	$52.13M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$52.05M	2.14	2.08	4.49	3.97
eXoZymes, Inc. (EXOZ)vs ›	$51.51M	N/A	N/A	N/A	N/A
ImageneBio Inc (IMA)vs ›	$53.24M	N/A	N/A	N/A	N/A
Aldeyra The (ALDX)vs ›	$53.30M	N/A	N/A	N/A	N/A
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$51.03M	N/A	N/A	N/A	N/A
Rani Therapeutics Holdings, Inc. (RANI)vs ›	$53.63M	N/A	N/A	N/A	N/A
Tenax Therapeutics, Inc. (TENX)vs ›	$50.93M	N/A	N/A	N/A	N/A
Spectral AI, Inc. (MDAI)vs ›	$53.78M	N/A	N/A	N/A	N/A

Operating Cash Flow Valuation

P/OCF Ratio

N/A

P/FCF Ratio

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/OCF Ratio: N/A

NMAD Price/OCF Ratio Metrics

NMAD Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics